Cellbxhealth PLC Announces Holding(s) in Company
Rhea-AI Summary
Cellbxhealth (OTC:ANPCF) disclosed a major holding notification: Conifer Management, L.L.C. crossed a threshold on 18-Dec-2025 and was notified to the issuer on 22-Dec-2025. The resulting situation shows Conifer holds 29.900% of voting rights, equating to 340,681,395 voting rights in Cellbxhealth. Shares are held in private funds managed by Conifer Management. The filing names Pershing LLC as the shareholder vehicle and lists Gregory Alexander as ultimate controlling person.
Positive
- 29.900% voting rights held by Conifer as of 18-Dec-2025
- 340,681,395 total voting rights held by Conifer
- Disclosure filed with issuer on 22-Dec-2025
Negative
- Concentration risk: single holder controls 29.900% voting rights
- Stake close to control threshold could influence corporate votes
Key Figures
Market Reality Check
Peers on Argus
The stock fell 14.72% pre-announcement while peers were mostly flat; notable moves include ANPCY at -55.07% and IZOZF at -1.16%, suggesting stock-specific pressure rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Oct 16 | Management changes | Neutral | -47.7% | Interim CEO and senior advisor appointed with planned restructure and funding. |
| Sep 12 | Board changes | Neutral | -59.3% | CEO and Finance Director stepped down after discussions with major shareholder. |
Recent leadership and governance news has coincided with sharply negative price reactions, even when the news itself was not clearly negative.
Over recent months, the company has undergone significant leadership and governance changes. On Sep 12, 2025, board changes and the departure of the CEO and Finance Director were followed by a -59.28% move. On Oct 16, 2025, appointment of a new interim CEO, a senior advisor, and a planned restructuring and funding in Q4 2025 saw a -47.7% reaction. Today’s major holdings disclosure fits into an ongoing period of ownership and governance reshaping.
Market Pulse Summary
This announcement details a major holdings notification, with Conifer Management-linked entities reporting 29.900000% of voting rights, equal to 340,681,395 votes in CelLBxHealth. It follows earlier governance changes and leadership transitions in 2025. Investors may focus on how this concentrated ownership interacts with an already depressed share price versus the 0.35 52-week high, as well as any future disclosures about strategic direction, restructuring, or additional governance developments.
Key Terms
isin financial
voting rights financial
financial instruments financial
proxy voting regulatory
AI-generated analysis. Not financial advice.
Cellbxhealth PLC: TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0034330679
Issuer Name
CelLBxHealth plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Conifer Management, L.L.C.
City of registered office (if applicable)
New York
Country of registered office (if applicable)
United States
4. Details of the shareholder
Name | City of registered office | Country of registered office |
Pershing LLC | Jersey City | USA |
5. Date on which the threshold was crossed or reached
18-Dec-2025
6. Date on which Issuer notified
22-Dec-2025
7. Total positions of person(s) subject to the notification obligation
. | % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer |
Resulting situation on the date on which threshold was crossed or reached | 29.900000 | 0.000000 | 29.900000 | 340681395 |
Position of previous notification (if applicable) |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
GB0034330679 | 340681395 | 29.900000 | ||
Sub Total 8.A | 340681395 | |||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
Sub Total 8.B1 | ||||
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2 | |||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Gregory Alexander | Conifer Management, LLC | 29.900000 |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Shares are held in private funds managed by Conifer Management, LLC
12. Date of Completion
22-Dec-2025
13. Place Of Completion
New York, NY
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
SOURCE: Cellbxhealth PLC
View the original press release on ACCESS Newswire